Investing in Innovation Africa Secured New Healthtech Deals
Healthcare operators can leverage these new partnerships to improve supply chain financing and expand digital patient engagement.
Updated on Sept. 29, 2026 in Healthcare
Live Poll
Do you believe digital technology improves healthcare access in underserved regions?
Investing in Innovation (i3) Africa has finalized four new healthtech partnerships designed to bolster pharmaceutical supply chains and improve healthcare access across the continent. These deals bring the program's total facilitated activity to 165 partnerships and pilots, collectively valued at more than $19 million.
Why it matters
The partnerships address critical infrastructure gaps by integrating digital credit-scoring for working capital and AI-driven regulatory tools. These developments reflect a broader industry push to modernize pharmaceutical distribution and patient management systems in emerging markets.
Supported startups have reached 6.85 million patients and tracked, protected, or distributed over 209 million health products. The i3 program has now facilitated 165 total partnerships and MOUs worth more than $19 million.
The players
Investing in Innovation (i3) Africa
An accelerator program that facilitates partnerships and funding to scale healthtech solutions across the continent.
Dawa Mkononi
A Tanzanian technology firm that provides working capital and supply chain solutions to healthcare facilities.
Sproxil
A digital supply chain company that develops authentication and audit systems for pharmaceutical product security.
MYDAWA
An e-health platform focused on increasing access to affordable medications and digital patient care models.
Boehringer Ingelheim
A major multinational pharmaceutical company that provides debt financing for infrastructure and market expansion.
The details
The initiative drives scale through specific operational integrations, such as Dawa Mkononi using credit-scoring platforms to provide interest-free working capital to Tanzanian facilities. Meanwhile, Sproxil is working with the Pharmacy Council of Nigeria to digitize regulatory audits using AI systems. Other partnerships include MYDAWA testing digital-first chronic disease care models and using WhatsApp for patient engagement.
Timeline
As of April 2026, supported startups had reached 6.85 million patients.
On September 29, 2026, i3 announced the four new healthtech partnerships.
Market Landscape
These partnerships follow an established trend toward the digital-first healthcare delivery transformation currently reshaping supply chains in Africa. The effort mirrors similar international programs that prioritize AI-led regulatory audit digitization to secure pharmaceutical integrity.
Operators in the healthcare supply chain should monitor how these credit-scoring and AI-audit models shift local pharmacy compliance standards. Businesses may need to re-evaluate their own digital engagement tools if they operate in markets where regulatory digitization is gaining momentum.
The takeaway
The move demonstrates that scaling healthtech requires a mix of financial liquidity tools and regulatory AI integration. Operators should track the success of these pilot projects as a signal for future technology requirements in emerging market pharmaceutical logistics.
Further reading
For more on industry shifts, see the Healthcare section.
Live Poll
Do you believe digital technology improves healthcare access in underserved regions?
